𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methylphenidate to treat ADHD is not contraindicated in children with tics

✍ Scribed by Roger Kurlan

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
100 KB
Volume
17
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neurocognitive effects of switching from
Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD
✍ Yeni Kim; Min-Sup Shin; Jae-Won Kim; Hee-Jung Yoo; Soo-Churl Cho; Boong-Nyun Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 129 KB

## Abstract ## Objectives This study evaluated neurocognitive changes after switching from immediate release forms of methylphenidate (MPH‐IR) to osmotic release oral system methylphenidate (OROS‐MPH). ## Methods 102 children with attention‐deficit/hyperactivity disorder (ADHD) participated in a

Use of levetiracetam to treat tics in ch
Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome
✍ Yasser Awaad; Anne Marie Michon; Sarah Minarik πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 108 KB

## Abstract Some drugs currently used to treat tics in pediatric patients have drawbacks, including the risk of side effects. New therapeutic options with better safety profiles are needed. Levetiracetam is an antiepileptic drug with atypical mechanisms of action that might be beneficial for this i

Response to methylphenidate in adults wi
Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1)
✍ J. Sandra Kooij; A. Marije Boonstra; Sita H. Vermeulen; Angelien G. Heister; Hui πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

## Abstract In this pharmacogenetic study in adults with ADHD (n = 42), a stratified analysis was performed of the association between response to methylphenidate (MPH), assessed under double‐blind conditions, and polymorphisms in the genes encoding the dopamine transporter, __SLC6A3 (DAT1)__, the

Prior fungal infection is not a contrain
Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia
✍ Hoover, Margo; Morgan, Elaine R.; Kletzel, Morris πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 43 KB πŸ‘ 2 views

## Purpose: Our aim was to assess the feasibility of bone marrow transplantation (bmt) in patients with acute leukemia who have had prior documented invasive fungal infection within 5 months pretransplant treated aggressively with systemic amphoteric in b and, when applicable, surgical resection of